173 related articles for article (PubMed ID: 19082791)
1. The characteristic change in the distribution of S-100 immunoreactive folliculostellate cells in rat anterior pituitary upon long-term estrogen treatment is prevented by concomitant progesterone treatment.
Heinzlmann A; Köves K
Endocrine; 2008 Jun; 33(3):342-8. PubMed ID: 19082791
[TBL] [Abstract][Full Text] [Related]
2. Effect of concomitant progesterone administration or the effect of removal of estrogen capsule on changes caused by long-term estrogen treatment in pituitary VIP immunoreactivities.
Heinzlmann A; Köves K; Nagy GM
Endocrine; 2010 Jun; 37(3):396-402. PubMed ID: 20960159
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of prolactin secretion from diethylstilbestrol-induced rat prolactinoma tissue in vitro.
Maas DL; Martinson DR; Erdmann MD; Wahle JS; Hagen TC
Proc Soc Exp Biol Med; 1995 Nov; 210(2):150-5. PubMed ID: 7568285
[TBL] [Abstract][Full Text] [Related]
4. Regulation of galanin gene expression in the rat anterior pituitary gland by the somatostatin analog SMS 201-995.
Hyde JF; Howard G
Endocrinology; 1992 Nov; 131(5):2097-102. PubMed ID: 1385097
[TBL] [Abstract][Full Text] [Related]
5. The importance of dopamine in the pathogenesis of experimental prolactinomas.
el-Azouzi M; Hsu DW; Black PM; Jolesz F; Hedley-Whyte ET; Klibanski A; Zervas NT
J Neurosurg; 1990 Feb; 72(2):273-81. PubMed ID: 1967303
[TBL] [Abstract][Full Text] [Related]
6. Sexual dimorphism in diethylstilbestrol-induced prolactin pituitary tumors in F344 rats.
Piroli GG; Torres A; Pietranera L; Grillo CA; Ferrini MG; Lux-Lantos V; Aoki A; De Nicola AF
Neuroendocrinology; 2000 Aug; 72(2):80-90. PubMed ID: 10971143
[TBL] [Abstract][Full Text] [Related]
7. mPRs represent a novel target for PRL inhibition in experimental prolactinomas.
Camilletti MA; Abeledo-Machado A; Perez PA; Faraoni EY; De Fino F; Rulli SB; Ferraris J; Pisera D; Gutierrez S; Thomas P; Díaz-Torga G
Endocr Relat Cancer; 2019 May; 26(5):497-510. PubMed ID: 30856609
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of pericytes in diethylstilbestrol (DES)-induced pituitary prolactinoma in rats.
Jindatip D; Fujiwara K; Sarachana T; Mutirangura A; Yashiro T
Med Mol Morphol; 2018 Sep; 51(3):147-155. PubMed ID: 29344720
[TBL] [Abstract][Full Text] [Related]
9. Levonorgestrel antagonism on estrogen-induced pituitary tumors is mediated by progesterone receptors.
Rey-Roldán EB; Grillo CA; Pietranera L; Libertun C; Nicola AF; Piroli GG
Horm Metab Res; 2008 Apr; 40(4):245-50. PubMed ID: 18548383
[TBL] [Abstract][Full Text] [Related]
10. Reduction of retinaldehyde dehydrogenase 1 expression and production in estrogen-induced prolactinoma of rat.
Fujiwara K; Davaadash B; Yatabe M; Kikuchi M; Horiguchi K; Kusumoto K; Kouki T; Yashiro T
Med Mol Morphol; 2008 Sep; 41(3):126-31. PubMed ID: 18807137
[TBL] [Abstract][Full Text] [Related]
11. Effects of diethylstilbestrol on the cytogenesis of prolactin cells in the pars distalis of the pituitary gland of the mouse.
Matsubara M; Harigaya T; Nogami H
Cell Tissue Res; 2001 Nov; 306(2):301-7. PubMed ID: 11702241
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen-induced prolactinoma in Fischer 344 rats.
Stepień H; Grochal M; Zieliński KW; Mucha S; Kunert-Radek J; Kulig A; Stawowy A; Pisarek H
J Endocrinol; 1996 Jul; 150(1):99-106. PubMed ID: 8708569
[TBL] [Abstract][Full Text] [Related]
13. Sexual dimorphism in the effect of concomitant progesterone administration on changes caused by long-term estrogen treatment in pituitary hormone immunoreactivities of rats.
Heinzlmann A; Koves K; Kovacs M; Csernus V
Med Sci Monit; 2011 Feb; 17(3):BR62-73. PubMed ID: 21358595
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of estrogen-induced pituitary tumor growth and angiogenesis in Fischer 344 rats by the matrix metalloproteinase inhibitor batimastat.
Mucha SA; Meleń-Mucha G; Godlewski A; Stepień H
Virchows Arch; 2007 Mar; 450(3):335-41. PubMed ID: 17235567
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms in progestin antagonism of pituitary tumorigenesis.
Piroli G; Torres A; Grillo C; Lux-Lantos V; Aoki A; De Nicola AF
J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):59-67. PubMed ID: 9569011
[TBL] [Abstract][Full Text] [Related]
16. Pituitary prolactin-secreting tumor formation: recent developments.
Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo herpetic vector-mediated gene transfer in the pituitary gland: impact on hormone secretion.
Bolognani F; Albariño C; Romanowski V; Carri NG; Goya RG
Eur J Endocrinol; 2001 Oct; 145(4):497-503. PubMed ID: 11581010
[TBL] [Abstract][Full Text] [Related]
18. The effects of hypokalaemia on the hormone exocytosis in adenohypophysis and prolactinoma cell culture model systems.
Molnár Z; Pálföldi R; László A; Radács M; László M; Hausinger P; Tiszlavicz L; Rázga Z; Valkusz Z; Gálfi M
Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):575-81. PubMed ID: 25054312
[TBL] [Abstract][Full Text] [Related]
19. Surface changes and hormone production in pituitary cells during tumorigenesis.
Khalil WK; Gáspár L; Szalai G; Julesz J; Galfi M
J Exp Clin Cancer Res; 1999 Dec; 18(4):553-8. PubMed ID: 10746984
[TBL] [Abstract][Full Text] [Related]
20. Changes in thrombospondin-1 levels in the endothelial cells of the anterior pituitary during estrogen-induced prolactin-secreting pituitary tumors.
Sarkar AJ; Chaturvedi K; Chen CP; Sarkar DK
J Endocrinol; 2007 Feb; 192(2):395-403. PubMed ID: 17283240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
